Whetstone Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sera Prognostics
SERA
|
+$8.99M |
| 2 |
Health Catalyst
HCAT
|
+$7.97M |
| 3 |
Freshworks
FRSH
|
+$7.09M |
| 4 |
LPRO
Open Lending Corp
LPRO
|
+$7.06M |
| 5 |
OPRA
Opera Ltd
OPRA
|
+$6.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$9.43M |
| 2 |
Remitly
RELY
|
+$6.48M |
| 3 |
FIVE9
FIVN
|
+$5.49M |
| 4 |
NCR Voyix
VYX
|
+$4.94M |
| 5 |
Definitive Healthcare
DH
|
+$2.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 66.68% |
| 2 | Healthcare | 12.57% |
| 3 | Communication Services | 9.54% |
| 4 | Consumer Discretionary | 7.71% |
| 5 | Financials | 3.11% |
Similar funds
Whetstone Capital Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Whetstone Capital Advisors held 38 positions worth $354M, up 56% from $226M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Whetstone Capital Advisors deployed $26M of net new capital in Q2 2025, opening 10 new positions and adding to 10 existing holdings. Its largest new stake was Sera Prognostics: 3,632,371 shares worth $10.1M.
By sector, the portfolio is most concentrated in Technology at 67% of assets, down from 69% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Unisys, an estimated $2.45M trimmed.
- Whetstone Capital Advisors's largest Q2 2025 buy was Sera Prognostics: 3,632,371 shares worth $10.1M.
- Whetstone Capital Advisors added most to Health Catalyst in Q2 2025, an estimated $7.97M increase.
- Whetstone Capital Advisors's biggest Q2 2025 reduction was Unisys, cutting an estimated $2.45M.
- Whetstone Capital Advisors fully exited Okta in Q2 2025, selling an estimated $9.43M.
- Whetstone Capital Advisors's ten largest holdings make up 78% of its $354M portfolio in Q2 2025.
- Whetstone Capital Advisors opened 10 new positions and closed 6 in Q2 2025.
- Whetstone Capital Advisors's portfolio value rose 56% quarter-over-quarter to $354M.
Based on Whetstone Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.